Last edition
News about "EBITDA"
Sai Life Sciences Eyes Global Expansion as Revenue Hits INR 1,115.1 Crore
The company reported a 15 percent increase in revenue and a 36 percent rise in net profit compared to the same period last year, driven by strong execution, expanding capacity, and deepening customer relationships.
EBITDA | 10/02/2025 | By Aishwarya
Zydus Reports Robust Growth in Q3 FY25 with a 17 Percent Increase in Revenue
Zydus Lifesciences recorded revenue from operations at INR 52,691 million, marking a 17 percent increase year-over-year.
EBITDA | 06/02/2025 | By Aishwarya
OneSource Achieves INR 3,926 Million Revenue in Q3FY25
OneSource demonstrated exceptional profitability with EBITDA reaching INR 1,432 million, an 85 percent increase compared to the previous quarter, resulting in a robust EBITDA margin of 36.5 percent, up by 1,334 basis points quarter-on-quarter.
EBITDA | 01/02/2025 | By Aishwarya
Strides Pharma Reports 21.3 Percent Growth in US Revenue in 9MFY25
The gross margin stood at INR 6,735 million, marking a 25.1 percent rise compared to the same quarter last year.
EBITDA | 31/01/2025 | By Aishwarya
Indegene Achieves Revenue of INR 6,868 Million in Q2FY25
In the second quarter of the financial year 2025, Indegene achieved revenue from operations totaling INR 6,868 million, marking an 8.0 percent Year-over-Year (YoY) growth compared to the same period in the previous year.
EBITDA | 29/10/2024 | By Aishwarya | 133
Gland Pharma Reports Remarkable Q4FY24 and FY24 Financial Performance
Gland Pharma Ltd. has announced its financial results for the fourth quarter (Q4FY24) and full year (FY24) ended on Mar 31, 2024.
EBITDA | 23/05/2024 | By Aishwarya | 156
Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 19.01 crore in Q1FY24, growth of 26.66% Y-o-Y
EBITDA | 11/08/2023 | By Sudeep Soparkar | 383
JB Pharma Records Revenue Growth of 14 Percent to INR 896 Crores in Q1 FY24
For the first quarter of FY24 ended June 30, 2023, JB Pharma recorded revenue of INR 896 crores growing 14 percent from INR 785 crores in the corresponding quarter.
EBITDA | 09/08/2023 | By Manvi | 515
Milestone Financial Year 2022 - 23 For Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has achieved the milestone of Rs. 533 crore Revenue & Rs. 100 crore Profit before tax for the first time in a financial year. Company has reported its Best-ever results in a financial year with the highest - Revenue, EBITDA and Net Profit during FY 2023.
EBITDA | 30/05/2023 | By Sudeep Soparkar | 344
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy